ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Triple Combination Therapy in High Risk Crohn's Disease (CD)

ClinicalTrials.gov ID: NCT02764762

Public ClinicalTrials.gov record NCT02764762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 2:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Phase 4 Study to Evaluate the Efficacy and Safety of Triple Combination Therapy With Vedolizumab IV, Adalimumab SC, and Oral Methotrexate in Early Treatment of Subjects With Crohn's Disease Stratified at Higher Risk for Developing Complications

Study identification

NCT ID
NCT02764762
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Takeda
Industry
Enrollment
55 participants

Conditions and interventions

Conditions

Interventions

  • Adalimumab Drug
  • Methotrexate Drug
  • Vedolizumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 17, 2017
Primary completion
Sep 21, 2020
Completion
Jul 4, 2022
Last update posted
Jul 13, 2023

2017 – 2022

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Digestive Health Specialists of the Southeast Dothan Alabama 36305
Gastro Florida Clearwater Florida 33761
Atlanta Gastroenterology Associates Atlanta Georgia 30342-5000
Grand Teton Research Group, PLLC Idaho Falls Idaho 83404
Northshore University HealthSystem Evanston Illinois 60201
University of Kansas Medical Center Kansas City Kansas 66160
Cotton O'Neil Clinical Research Topeka Kansas 66606
Texas Digestive Disease Consultants Baton Rouge Baton Rouge Louisiana 70809
Louisana Research Center, LLC Shreveport Louisiana 71105
Center for Digestive Health Troy Michigan 48098
Huron Gastroenterology Associates Ypsilanti Michigan 48197
Minnesota Gastroenterology, PA - Plymouth Plymouth Minnesota 55446
University of Mississippi Medical Center Jackson Mississippi 39216
Las Vegas Medical Research Las Vegas Nevada 89113
Icahn School of Medicine at Mt. Sinai New York New York 10029
Digestive Health Partners, PS Asheville North Carolina 28801
Carolinas HealthCare System Digestive Health Charlotte North Carolina 28204
The Ohio State University Wexner Medical Center Columbus Ohio 43210
Digestive Disease Specialists, Inc. Oklahoma City Oklahoma 73112
Options Health Research, LLC Tulsa Oklahoma 74104
Baylor College of Medicine Houston Texas 77030
Pinnacle Clinical Research San Antonio Texas 78229
Texas Digestive Disease Consultants Southlake Southlake Texas 76092
Tyler Research Institute, LLC Tyler Texas 75701
Texas Digestive Disease Consultants, Webster Webster Texas 77598
University of Utah Health Sciences Center Salt Lake City Utah 84132
Digestive Health Specialists Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02764762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2023 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02764762 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →